(Q35824482)

10 August 2017

1 reference

title

Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

10 August 2017

0 references

author name string

R P Rother

series ordinal

1

1 reference

10 August 2017

C F Mojcik

series ordinal

2

1 reference

10 August 2017

E W McCroskery

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

13

1 reference

10 August 2017

5

1 reference

10 August 2017

328-334

1 reference

The key role of nucleosomes in lupus

10 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Nephritogenic autoantibodies in lupus: current concepts and continuing controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Novel approaches in the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Newer drugs for the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

C5A anaphylatoxin and its seven transmembrane-segment receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Complement-specific antibodies: designing novel anti-inflammatories

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Complement and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Membrane signaling by complement C5b-9, the membrane attack complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Partial C4A deficiency is associated with susceptibility to systemic lupus erythematosus in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Identification of a novel mutation (Tyr1081Ter) in sisters with hereditary component C3 deficiency and SLE-like symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Rheumatic syndromes associated with complement deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

21 January 2018

Complement and apoptosis

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

C1q knock-out mice for the study of complement deficiency in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Elimination of soluble123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Lupus and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Cardiovascular manifestations of systemic lupus erythematosus: current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Complement and the Kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Elevated urinary excretion of the C5b-9 complex in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

Natural history of paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1021OA

10.1191/0961203303LU1021OA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference